載入...
In-vitro and in-vivo combined effect of ARQ 092, an AKT inhibitor, with ARQ 087, a FGFR inhibitor
The PI3K/AKT pathway plays an important role in the initiation and progression of cancer, and the drug development efforts targeting this pathway with therapeutic interventions have been advanced by academic and industrial groups. However, the clinical outcome is moderate. Combination of inhibition...
Na minha lista:
| 發表在: | Anticancer Drugs |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Lippincott Williams & Wilkins
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5404396/ https://ncbi.nlm.nih.gov/pubmed/28240679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0000000000000486 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|